Catalyst Wire Dossier Catalyst Wire Dossier

Ranibizumab (Lucentis)

ranibizumab · Genentech
Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for Ranibizumab (Lucentis), covering 2007-10-08 to 2019-02-15. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Switching From Aflibercept to Ranibizumab in Patients With nAMD [Phase 4]

See pricing